News

PathPresenter Closes $7.5M Series A Funding Led by AVANT BIO

PathPresenter, the global image sharing platform for pathology announced that it has closed a Series A funding round of $7.5M to accelerate the adoption of the company’s enterprise pathology workflow solution. Joined by 3 additional investors, the AVANT BIO led round will be used to advance the features of their vendor-agnostic platform, invest in talent across engineering and commercial functions, and accelerate the achievement of regulatory milestones.

PathPresenter’s story is quite unique, founded by dermatopathologist and digital pathology pioneer, Dr. Rajendra Singh, it began as a free online platform for pathology education. Rapidly becoming the world’s largest and fastest growing digital pathology community with 50,000+ users in 172 countries. The company began building a secure and scalable enterprise platform and extended the pathology use cases to include clinical care, remote consultations and research, partnering with visionary 3rd party vendors to create the most comprehensive and interoperable pathology workflow solution available.

AVANT BIO is proud to support PathPresenter’s mission to leverage Tech Bio to advance preventative solutions and improve patient outcomes.

Read PathPresenter’s press release here.

Please follow PathPresenter on LinkedIn to keep up with their latest news

Visit PathPresenter to learn more about their technology.